Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to provide an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences, part of the South Korean LG Group, to develop Affimer therapeutics in several disease areas.
Read More
Health Rss 